| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jason P Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J Budney, Wayne D Hal. Cannabis use and cannabis use disorder. Nature reviews. Disease primers. vol 7. issue 1. 2021-11-25. PMID:33627670. |
treatment of cannabis use and cud is often complicated by comorbid mental health and other substance use disorders. |
2021-11-25 |
2023-08-13 |
Not clear |
| Jason P Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J Budney, Wayne D Hal. Cannabis use and cannabis use disorder. Nature reviews. Disease primers. vol 7. issue 1. 2021-11-25. PMID:33627670. |
the legalization of non-medical cannabis use in some high-income countries may increase the prevalence of cud by making more potent cannabis products more readily available at a lower price. |
2021-11-25 |
2023-08-13 |
Not clear |
| Jason P Connor, Daniel Stjepanović, Bernard Le Foll, Eva Hoch, Alan J Budney, Wayne D Hal. Cannabis use and cannabis use disorder. Nature reviews. Disease primers. vol 7. issue 1. 2021-11-25. PMID:33627670. |
states that legalize medical and non-medical cannabis use should inform users about the risks of cud and provide information on how to obtain assistance if they develop cannabis-related mental and/or physical health problems. |
2021-11-25 |
2023-08-13 |
Not clear |
| John R Moore, Diana M DiNitto, Namkee G Cho. Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use. The American journal on addictions. vol 30. issue 5. 2021-11-25. PMID:34143567. |
screening, brief intervention, and referral to treatment (sbirt) can reduce substance use, but receipt of these services by those who use cannabis frequently and have cannabis use disorder (cud) remains unexplored. |
2021-11-25 |
2023-08-13 |
Not clear |
| John R Moore, Diana M DiNitto, Namkee G Cho. Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use. The American journal on addictions. vol 30. issue 5. 2021-11-25. PMID:34143567. |
we examined cannabis use frequency and cud's associations with the odds of receiving a substance use screening and a healthcare professional discussion among those who used healthcare services. |
2021-11-25 |
2023-08-13 |
Not clear |
| Rikinkumar S Patel, Mario D Gonzalez, Temitope Ajibawo, Raman Bawej. Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults. The American journal on addictions. vol 30. issue 6. 2021-11-25. PMID:34432919. |
we studied the relationship between cannabis use disorder (cud) and arrhythmia hospitalization. |
2021-11-25 |
2023-08-13 |
Not clear |
| Fouad Chouairi, P Elliott Miller, Avirup Guha, John-Ross Clarke, Samuel W Reinhardt, Tariq Ahmad, James V Freeman, Nihar R Desai, Daniel J Friedma. Cannabis use disorder among atrial fibrillation admissions, 2008-2018. Pacing and clinical electrophysiology : PACE. vol 44. issue 11. 2021-11-24. PMID:34506639. |
despite changes inthe legality of cannabis use and the increasing prevalence of cannabis use disorder (cud), there is little data investigating the association between cud and inpatient atrial fibrillation (af) hospitalizations. |
2021-11-24 |
2023-08-13 |
Not clear |
| Ayla Selamoglu, Christelle Langley, Rebecca Crean, George Savulich, Francesca Cormack, Barbara J Sahakian, Barbara Maso. Neuropsychological performance in young adults with cannabis use disorder. Journal of psychopharmacology (Oxford, England). vol 35. issue 11. 2021-11-20. PMID:34694178. |
here, we study daily cannabis users with a confirmed diagnosis of cannabis use disorder (cud) to examine cognitive performance on measures of memory, executive function and risky decision-making. |
2021-11-20 |
2023-08-13 |
Not clear |
| Angélica Meinhofer, Jesse M Hinde, Katherine M Keyes, Claudia Lugo-Candela. Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy. JAMA psychiatry. 2021-11-19. PMID:34730782. |
prenatal cannabis use continues to increase, yet studies of the demographic, psychiatric, and medical characteristics associated with cannabis use in pregnancy are limited by size and use of self-report, and often do not consider cannabis use disorder (cud) or concomitant substance use disorders (suds). |
2021-11-19 |
2023-08-13 |
Not clear |
| Julen Marín, Xabier Pérez de Mendiola, Sergio Fernández, Juan Pablo Char. Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic. Journal of addictive diseases. vol 39. issue 4. 2021-11-17. PMID:33884940. |
cannabis withdrawal syndrome (cws) is a key feature of cannabis use disorder (cud). |
2021-11-17 |
2023-08-13 |
Not clear |
| Arpit Parmar, Rakesh Lal, Siddharth Sarkar, Yatan Pal Singh Balhar. Neurological Soft Signs in Cannabis Use Disorder with or without Psychosis: A Comparative Study from India. Journal of dual diagnosis. vol 17. issue 4. 2021-11-17. PMID:34609263. |
the purpose of this study was to assess and compare neurological soft signs in patients of cannabis use disorder (cud) with and without co-occurring psychosis in a treatment-seeking sample. |
2021-11-17 |
2023-08-13 |
Not clear |
| Joseph Aloi, Marie C McCusker, Brandon J Lew, Mikki Schantell, Jacob A Eastman, Michaela R Frenzel, Tony W Wilso. Altered amygdala-cortical connectivity in individuals with Cannabis use disorder. Journal of psychopharmacology (Oxford, England). vol 35. issue 11. 2021-11-17. PMID:34730052. |
prior literature using task-based functional magnetic resonance imaging (fmri) has identified that individuals with cannabis use disorder (cud) show impairments in emotion processing circuitry. |
2021-11-17 |
2023-08-13 |
Not clear |
| Fouad Chouairi, Clancy W Mullan, Neal Ravindra, Katherine A A Clark, Edward M Jaffe, Jasjit Bhinder, Michael Fuery, Avirup Guha, Tariq Ahmad, Nihar R Desa. Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018. PloS one. vol 16. issue 9. 2021-11-16. PMID:34591847. |
in the united states, both cannabis use disorder (cud) and opioid use disorder (oud) have increased in prevalence. |
2021-11-16 |
2023-08-13 |
Not clear |
| Carsten Hjorthøj, Md Jamal Uddin, Theresa Wimberley, Søren Dalsgaard, David M Hougaard, Anders Børglum, Thomas Werge, Merete Nordentof. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:31813396. |
cannabis use and cannabis use disorder (cud) is increased in patients with schizophrenia. |
2021-11-12 |
2023-08-13 |
Not clear |
| Rachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, George Stothart, Marta Di Forti, Eva Hoch, Tom P Freema. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:33536109. |
cannabis is the most widely used illicit drug worldwide, and it is estimated that up to 30% of people who use cannabis will develop a cannabis use disorder (cud). |
2021-11-12 |
2023-08-13 |
Not clear |
| Rachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, George Stothart, Marta Di Forti, Eva Hoch, Tom P Freema. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:33536109. |
demand for treatment of cud is increasing in almost every region of the world and cannabis use is highly comorbid with mental disorders, where sustained use can reduce treatment compliance and increase risk of relapse. |
2021-11-12 |
2023-08-13 |
Not clear |
| Rachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, George Stothart, Marta Di Forti, Eva Hoch, Tom P Freema. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:33536109. |
pharmacological treatments targeting the endocannabinoid system have the potential to reduce cannabis withdrawal and cannabis use in cud. |
2021-11-12 |
2023-08-13 |
Not clear |
| Rachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, George Stothart, Marta Di Forti, Eva Hoch, Tom P Freema. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:33536109. |
antipsychotic medication may decrease cannabis use and cannabis craving as well as psychotic symptoms in patients with cud and psychosis. |
2021-11-12 |
2023-08-13 |
Not clear |
| Haitao Zhang, Bridget F Grant, Colin A Hodgkinson, W June Ruan, Bradley T Kerridge, Boji Huang, Tulshi D Saha, Amy Z Fan, Veronica Wilson, Jeesun Jung, Abbas Parsian, David Goldman, S Patricia Cho. Strong and weak cross-inheritance of substance use disorders in a nationally representative sample. Molecular psychiatry. 2021-11-11. PMID:34759357. |
we performed exome-focused genotyping to examine the cross-transmission of four suds: alcohol use disorder (aud, n = 4487); nicotine use disorder (nud, n = 4394); cannabis use disorder (cud, n = 954); and nonmedical prescription opioid use disorder (nmpoud, n = 346) within a large nationally representative sample (n = 36,309), the national epidemiologic survey on alcohol and related conditions-iii (nesarc-iii). |
2021-11-11 |
2023-08-13 |
Not clear |
| Brian J Sherman, Michael J Sofis, Jacob T Borodovsky, Kevin M Gray, Aimee L McRae-Clark, Alan J Budne. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2021-11-09. PMID:34197135. |
abstinence is rarely achieved in clinical trials for cannabis use disorder (cud). |
2021-11-09 |
2023-08-13 |
Not clear |